Segment Information (Tables)

9 Months Ended

Sep. 30, 2012

Segment Information [Abstract]

Revenues, Cost Of Services And Products, And Gross Margins For Operating Segments

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2012		2011		2012		2011
Revenues:
Preservation services	$	16,399	$	14,656	$	48,371	$	45,018
Medical devices		16,893		14,923		50,043		43,932
Othera		137		75		504		279
Total revenues		33,429		29,654		98,918		89,229
Cost of preservation services and products:
Preservation services		9,005		8,349		26,645		25,709
Medical devices		3,114		2,393		8,300		7,051
Total cost of preservation services and products		12,119		10,742		34,945		32,760
Gross margin:
Preservation services		7,394		6,307		21,726		19,309
Medical devices		13,779		12,530		41,743		36,881
Othera		137		75		504		279
Total gross margin	$	21,310	$	18,912	$	63,973	$	56,469

Summary Of Net Revenues By Product

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2012		2011		2012		2011
Preservation services:
Cardiac tissue	$	8,239	$	6,764	$	22,662	$	19,989
Vascular tissue		8,160		7,892		25,709		25,029
Total preservation services		16,399		14,656		48,371		45,018
Products:
BioGlue and BioFoam		12,725		12,190		39,858		36,936
PerClot		734		620		2,069		1,911
HemoStase		--		--		--		1,795
Revascularization technologies		2,060		2,113		6,107		3,290
HeRO Graft		1,374		--		2,009		--
Total products		16,893		14,923		50,043		43,932
Othera		137		75		504		279
Total revenues	$	33,429	$	29,654	$	98,918	$	89,229

___________________

^aFor the three and nine months endedSeptember 30, 2012 and 2011, the “Other” designation includes grant revenue.